Bin Cheng
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Hepatology top 5%
Papers in
-
- Epigenetics and DNA Methylation 8
- Oncology 26
- Pancreatic and Hepatic Oncology Research 11
- Cancer Cells and Metastasis 8
- Co-authors
- Ronghua Wang (22 shared papers)Si Xiong (25 shared papers)Yawen Li (12 shared papers)Xiju Wang (10 shared papers)Yuchong Zhao (30 shared papers)Kai Wang (3 shared papers)Qingzhu Gao (2 shared papers)Ni Tang (3 shared papers)
- Journals
- Carcinogenesis (3 papers)International Journal of Oncology (2 papers)Oncotarget (2 papers)Virology Journal (2 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bin Cheng
100 papers receiving 2.4k citations
Bin Cheng's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 554
- Hepatology 230
- Oncology 639
- Molecular Biology 925
- Pulmonary and Respiratory Medicine 325
Countries citing papers authored by Bin Cheng
This map shows the geographic impact of Bin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Cheng more than expected).
Fields of papers citing papers by Bin Cheng
This network shows the impact of papers produced by Bin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Cheng. The network helps show where Bin Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis Hit paper breakdown → | 2021 | 254 |
| 2 | 2015 | 136 | |
| 3 | 2018 | 134 | |
| 4 | Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling. | 2018 | 113 |
| 5 | 2004 | 106 | |
| 6 | 2017 | 103 | |
| 7 | 2018 | 75 | |
| 8 | 2015 | 67 | |
| 9 | 2018 | 65 | |
| 10 | 2007 | 62 | |
| 11 | Liver volume in patients with or without chronic liver diseases. | 1998 | 60 |
| 12 | 2019 | 57 | |
| 13 | 2020 | 54 | |
| 14 | 2021 | 47 | |
| 15 | 2006 | 47 | |
| 16 | 2017 | 41 | |
| 17 | 2010 | 39 | |
| 18 | 2018 | 37 | |
| 19 | 2014 | 37 | |
| 20 | 2012 | 33 |
About Bin Cheng
Bin Cheng is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Epidemiology, having authored 103 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cancer Cells and Metastasis (8 papers), Epigenetics and DNA Methylation (8 papers), Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers), Hepatitis B Virus Studies (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Cancer Research (554 citations), Hepatology (230 citations), Oncology (639 citations), Molecular Biology (925 citations) and Pulmonary and Respiratory Medicine (325 citations). Bin Cheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ronghua Wang, Si Xiong, Yawen Li, Xiju Wang, Yuchong Zhao, Kai Wang, Qingzhu Gao, Ni Tang, Ailong Huang and Qiang Xue. Their work appears in journals such as Carcinogenesis, International Journal of Oncology, Oncotarget, Virology Journal and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.